In the latest edition of STAT's Health Tech newsletter: Biofourmis turmoil, Alex...
Humana sued the federal government Friday over a rule that claws back overpaymen...
Residents of disadvantaged neighborhoods were far more likely to be allocated a ...
The FTC had challenged the deal over concerns the combined company could abuse i...
J&J's Stelara was approved 98 days too early to qualify for an exemption from Me...
Most states are not in compliance with this ACA requirement.
While billions of dollars are invested in new gene-therapy approaches, AstraZene...
When it comes to the Biden administration's selection of 10 drugs subject to pri...
A working paper suggests one way to get more doctors into primary care: Changing...
Though still in mouse experiments, a new, precise gene editing trick could lead ...
Otsuka Pharmaceutical has signed a definitive arrangement agreement to acquire M...
Twist and Ono will discover and develop novel antibodies to treat autoimmune dis...
The $15m acquisition would give Zerva rights to Acer’s FDA-approved rare Urea cy...
The company announced a strategic shake-up that includes layoffs, leadership cha...
NexImmune will reduce its workforce from 47 to just 22 full-time employees and h...
Bayer adds three new Phase III heart failure studies to the Kidney and type 2 di...
